IL1A and type 2 diabetes mellitus: T2DM-SMC exhibited significantly increased senescence-associated (SA) β-gal staining (Figure 1A), increased expression of IL-1α mRNA (Figure 1B), and reduced expression of nuclear lamin B1 mRNA (LMNB1) [20] (Figure 1C), relative to ND-SMC.